Home NDC 11822-6451-01 NDC 11822-6451-01 - pain relief aspirin Low Dose This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 11822-6451
Requested NDC 11822-6451-01
Package NDCs from labels 11822-6451-1, 11822-6451-4, 11822-6451-6, 11822-6451-01
Manufacturer Rite Aid Corporation | LNK International, Inc.
Effective date 2026-08-05
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Rite Aid 44-645 Rite Aid Corporation | LNK International, Inc. 2026-08-05 HUMAN OTC DRUG LABEL
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 11822-6451-1 pain relief aspirinLow Dose 120 in 1 BOTTLE, PLASTIC TABLET, DELAYED RELEASE 120 14 11822-6451-1 pain relief aspirinLow Dose 1 in 1 CARTON TABLET, DELAYED RELEASE 1 14 11822-6451-4 pain relief aspirinLow Dose 500 in 1 BOTTLE, PLASTIC TABLET, DELAYED RELEASE 500 14 11822-6451-6 pain relief aspirinLow Dose 1 in 1 CARTON TABLET, DELAYED RELEASE 1 14 11822-6451-6 pain relief aspirinLow Dose 200 in 1 BOTTLE TABLET, DELAYED RELEASE 200 14
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 11822-6451 PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, DELAYED RELEASE [RITE AID CORPORATION] 13 Current NDC, Legacy NDC, 5 package rows 20240829_df7835c9-f10f-40c6-8955-61423d94b677.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ASPIRIN ACTIVE INGREDIENT R16CO5Y76E PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 ASPIRIN ACTIVE MOIETY R16CO5Y76E PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 METHACRYLIC ACID INACTIVE INGREDIENT 1CS02G8656 PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 POLYDEXTROSE INACTIVE INGREDIENT VH2XOU12IE PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 SODIUM BICARBONATE INACTIVE INGREDIENT 8MDF5V39QO PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 TALC INACTIVE INGREDIENT 7SEV7J4R1U PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1 TRIETHYL CITRATE INACTIVE INGREDIENT 8Z96QXD6UM PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID] 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 6 of 274 · 5,474 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Acetaminophen ACETAMINOPHEN PD-Rx Pharmaceuticals, Inc. 3f96aeb1-a533-4d36-9a1f-62fc094b6754 2026-10-26 Warnings Exact identifier application number: M013 HERA SILKYSTAY FOUNDATION 26N1 TITANIUM DIOXIDE Amorepacific Corporation 5ec7151e-4f83-4aca-e063-6294a90a9818 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 26W1 TITANIUM DIOXIDE Amorepacific Corporation 5ec7276d-fcaf-65b2-e063-6394a90ac220 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 28C1 TITANIUM DIOXIDE Amorepacific Corporation 5ec73566-5d67-7153-e063-6394a90aba33 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 28N1 TITANIUM DIOXIDE Amorepacific Corporation 5ec75100-153c-80cd-e063-6294a90a6d51 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 28O1 TITANIUM DIOXIDE Amorepacific Corporation 5ec77f7a-4621-ac0c-e063-6294a90a3f70 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 29N1 TITANIUM DIOXIDE Amorepacific Corporation 5ec7ab15-9cc1-d53a-e063-6294a90a4111 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 29W1 TITANIUM DIOXIDE Amorepacific Corporation 5ec83b87-08bc-7590-e063-6294a90a0b78 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 31C1 TITANIUM DIOXIDE Amorepacific Corporation 5ec857a3-7fd1-6461-e063-6394a90aacd7 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 31N1 TITANIUM DIOXIDE Amorepacific Corporation 5ec871dc-f74e-765c-e063-6394a90a27a5 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP Acetaminophen PM Extra Strength ACETAMINOPHEN, DIPHENHYDRAMINE HCL FOODHOLD U.S.A., LLC fdd7ce80-d6be-41b9-affd-d024cf306b50 2026-10-26 Warnings Exact identifier application number: M013 Bacteriostatic Water WATER Henry Schein, Inc. a833502e-a622-4e81-8c58-cef6ccb6c4c9 2026-10-26 Boxed warning, Warnings, Adverse reactions Exact identifier unii: 059QF0KO0R Headache Relief Extra Strength ACETAMINOPHEN, ASPIRIN, CAFFEINE CVS Pharmacy 9e459853-5951-4ae7-88a6-85b502e9dd41 2026-10-26 Warnings Exact identifier application number: M013 unii: R16CO5Y76E HERA SILKYSTAY FOUNDATION 13N1 TITANIUM DIOXIDE Amorepacific Corporation 5eb19976-6983-3d9e-e063-6394a90a01ee 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 17C2 TITANIUM DIOXIDE Amorepacific Corporation 5eb338c7-e99c-887d-e063-6394a90a977c 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 17N1 TITANIUM DIOXIDE Amorepacific Corporation 5eb363fe-c2b2-9381-e063-6294a90ad038 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 17W1 TITANIUM DIOXIDE Amorepacific Corporation 5eb39387-7f6b-ce78-e063-6394a90a15ae 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 21C2 TITANIUM DIOXIDE Amorepacific Corporation 5eb3c3ad-8a77-0655-e063-6394a90ae9e0 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 21N1 TITANIUM DIOXIDE Amorepacific Corporation 5eb3ddb5-4e2b-17d4-e063-6394a90aaa55 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 22N1 TITANIUM DIOXIDE Amorepacific Corporation 5eb415b3-b1ba-42b8-e063-6394a90a90d7 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.